Electrotherapy System Market - Insights
Electrotherapy system includes medical devices, which are used in management of chronic pain, wound healing, neuromuscular disorders, musculoskeletal disorders, and others. Electrotherapy works by relaxing the muscles, preventing and retarding disuse atrophy, and muscle rehabilitation. It is used by athletic trainers and therapists to treat athletic injuries. Moreover, in neuromuscular disorders, electrotherapy is used to support voluntary movement and build muscles through activation of muscle systems and neuromuscular facilitation.
Approval and launch of novel electrotherapy systems of neuromuscular diseases is expected to drive growth of the global electrotherapy system market
Key manufacturers such as Innovative Neurological Devices, Medtronic Plc. and others are focusing on extensive research and development and gaining regulatory approvals for their products. For instance, in March 2019, Innovative Neurological Devices received the U.S. Food and Drug Administration (FDA) approval for CERVELLA, a cranial electrotherapy stimulator for treating anxiety, insomnia, and depression.
In September 2018, Medtronic Plc. announced the U.S. Food and Drug Administration approval of Intellis Platform, a spinal cord stimulation used for managing different types of chronic intractable pain.
Moreover, in July 2013, DJO Global received the U.S. Food and Drug Administration approval for Empi Phoenix, it is used in patients undergoing anterior cruciate ligament (ACL) reconstruction, and total knee arthroplasty to avoid muscle atrophy. The device also helps in reducing swelling, and pain management.
The electrotherapy system market has been witnessing high demand which has led to the development of innovative electrotherapy systems. For instance, in September 2017, CEFALY Technology received the U.S. Food and Drug Administration approval for CEFALY, a medical device used for acute treatment of migraine in patients’ aged 18 years and above. CEFALY is an external trigeminal nerve stimulator (e-TNS) approved for use in migraine under prescription.
Increasing prevalence and incidence of chronic pain and neuromuscular diseases is expected to propel the global electrotherapy system market growth
Increasing incidence of neuromuscular disorders, owing to increasing problems such as weakening of muscle and nerves is expected to drive global electrotherapy system market growth. For instance, in 2015, the National Center for Biotechnology Information (NCBI) reported incidence rates for several neuromuscular disorders, which ranged from 0.05 to 9 per 100,000 population per year.
Moreover, increasing prevalence of migraine worldwide is expected to be a key factor driving the global electrotherapy system market growth. For instance, according to the National Center for Biotechnology Information (NCBI), in 2016, the global prevalence of migraine was 14.7% (1 out of 7 people).
The global electrotherapy system market size was valued at US$ 891.3 Mn in 2018 and is expected to witness a CAGR of 4.6% over the forecast period, (2019 – 2027).
Figure 1. Global Electrotherapy System Market Share (%), By End User, 2019 - 2027
Source: Coherent Market Insights Analysis (2019)
Regional segmentation of the global electrotherapy system market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold the dominant position in the global electrotherapy system market, owing to presence of key players such as Medtronic Plc., DJO Global Inc., Nevro Corporation, Cyberonics, Inc,, and others.
Furthermore, the Europe electrotherapy system market is expected to grow over the forecast period due to rising prevalence of chronic pain conditions, and neuromuscular diseases. For instance, according to the British Medical Journal (BMJ) 2016, prevalence of chronic pain in Europe ranged from 35.0% to 51.3%, prevalence of moderate disabling chronic pain ranged from 10.4% to 14.3% in adults, while prevalence of chronic pain in people in the age group of 18–39?years is 30%. Moreover, according to same source, chronic pain conditions occurs frequently in females in comparison to males.
Restrains of Global Electrotherapy System Market
Factors restraining the growth of global electrotherapy system market are availability of alternative treatment such as, drug treatment for chronic pain condition and neuromuscular disorders. There are few side effects of electrotherapy system such as skin irritation, rashes caused by adhesives used for electrodes, or the tape used for holding the electrodes in place, while over usage of electrotherapy system causes burning sensation in skin.
Figure 2. Global Electrotherapy System Market Share (%) Analysis, By Region, 2019 and 2027
Source: Coherent Market Insights Analysis (2019)
Key players operating in the global electrotherapy system market include Medtronic Plc., Zealmax Innovation Pvt Ltd, Zynex, Inc., DJO Global Inc., Nevro Corporation, Cyberonics, Inc., BTL Industries Inc., EMS Physio Ltd, STYMCO Technologies LLC, and Omron Healthcare Inc.
Electrotherapy system includes medical devices that use electrical energy for medical treatment. These electrical impulses are used for treating soft tissue injuries and to stimulate muscles in order to improve muscle sensation and strength. These devices use energy waves with the electromagnetic spectrum in pain treatment. Electrotherapy systems have application in wound healing, neuromuscular dysfunction, pain management, musculoskeletal disorders, and others.
Approvals and product launches in key regions is expected to be a major factor driving the global electrotherapy system market growth over the forecast period.
In November 2017, Excel Health Inc. announced that the company had received U.S. Food and Drug Administration (FDA) clearance for its PlayMakar Wireless EMS + TENS unit, a wearable tool that helps in treating acute and chronic pain symptoms such as arthritis.
According to the World Health Organization (WHO), in June 2019, around 50 million people across the globe were suffering from epilepsy. The high incidence of neurological diseases in key regions is expected to drive growth of the global electrotherapy system market over the forecast period.
According to the National Institutes of Health (NIH), in 2016, around 20% of the U.S. population suffered from chronic pain and 8% of population had severe chronic pain. Moreover, in 2017, according to the American Academy of Pain Medicine, more than 1.5 billion people globally suffered from chronic pain.
Key features of the study:
“*” Marked represents similar segmentation in other categories in the respective section
Table of Contents
*Browse 43 market data tables and 31 figures on “Electrotherapy System Market - Global forecast to 2027.
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.